{"id":"https://openalex.org/W2509102166","doi":"https://doi.org/10.1097/hjh.0000000000001052","title":"Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs meta-analyses of randomized trials","display_name":"Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs meta-analyses of randomized trials","alternate_titles":[],"publication_year":2016,"publication_date":"2016-07-22","ids":{"openalex":"https://openalex.org/W2509102166","doi":"https://doi.org/10.1097/hjh.0000000000001052","mag":"2509102166","pmid":"https://pubmed.ncbi.nlm.nih.gov/27454050"},"language":"en","primary_location":{"id":"doi:10.1097/hjh.0000000000001052","doi":"https://doi.org/10.1097/hjh.0000000000001052","is_oa":false,"landing_page_url":"https://doi.org/10.1097/hjh.0000000000001052","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2509102166"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065539150","display_name":"Costas Thomopoulos","orcid":"https://orcid.org/0000-0002-8491-6029","observed_orcids":["https://orcid.org/0000-0002-8491-6029"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210134201","display_name":"IRCCS Istituto Auxologico Italiano","ror":"https://ror.org/033qpss18","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210134201","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I66752286","display_name":"University of Milano-Bicocca","ror":"https://ror.org/01ynf4891","country_code":"IT","type":"education","lineage":["https://openalex.org/I66752286"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Costas Thomopoulos","raw_affiliation_strings":["aDepartment of Cardiology, Helena Venizelou Hospital, Athens, Greece bDepartment of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano IRCCS cDepartment of Medicine and Surgery, University of Milan Bicocca dScientific Direction, Istituto Auxologico Italiano IRCCS eCentro Interuniversitario di Fisiologia Clinica e Ipertensione, Universit\u00e0 degli Studi di Milano, Milan, Italy","AE, adverse events; Abbreviations: ACE, angiotensin-converting enzyme; Accepted 28 June, 2016; BP, blood pressure; CHD, coronary heart disease; CI, confidence interval; NNT, number needed to treat; RCT, randomized controlled trial; RR, risk ratio; Received 13 May, 2016; Revised 16 June, 2016; aDepartment of Cardiology, Helena Venizelou Hospital, Athens, Greece; bDepartment of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano IRCCS; cDepartment of Medicine and Surgery, University of Milan Bicocca; e-mail: [email\u00a0protected]; eCentro Interuniversitario di Fisiologia Clinica e Ipertensione, Universit\u00e0 degli Studi di Milano, Milan, Italy; fax: +39 02 619112901"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aDepartment of Cardiology, Helena Venizelou Hospital, Athens, Greece bDepartment of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano IRCCS cDepartment of Medicine and Surgery, University of Milan Bicocca dScientific Direction, Istituto Auxologico Italiano IRCCS eCentro Interuniversitario di Fisiologia Clinica e Ipertensione, Universit\u00e0 degli Studi di Milano, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I4210134201","https://openalex.org/I66752286"]},{"raw_affiliation_string":"AE, adverse events; Abbreviations: ACE, angiotensin-converting enzyme; Accepted 28 June, 2016; BP, blood pressure; CHD, coronary heart disease; CI, confidence interval; NNT, number needed to treat; RCT, randomized controlled trial; RR, risk ratio; Received 13 May, 2016; Revised 16 June, 2016; aDepartment of Cardiology, Helena Venizelou Hospital, Athens, Greece; bDepartment of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano IRCCS; cDepartment of Medicine and Surgery, University of Milan Bicocca; e-mail: [email\u00a0protected]; eCentro Interuniversitario di Fisiologia Clinica e Ipertensione, Universit\u00e0 degli Studi di Milano, Milan, Italy; fax: +39 02 619112901","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I4210134201"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015206826","display_name":"Gianfranco Parati","orcid":"https://orcid.org/0000-0001-9402-7439","observed_orcids":["https://orcid.org/0000-0001-9402-7439"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210134201","display_name":"IRCCS Istituto Auxologico Italiano","ror":"https://ror.org/033qpss18","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210134201","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gianfranco Parati","raw_affiliation_strings":["AE, adverse events; Abbreviations: ACE, angiotensin-converting enzyme; Accepted 28 June, 2016; BP, blood pressure; CHD, coronary heart disease; CI, confidence interval; NNT, number needed to treat; RCT, randomized controlled trial; RR, risk ratio; Received 13 May, 2016; Revised 16 June, 2016; aDepartment of Cardiology, Helena Venizelou Hospital, Athens, Greece; bDepartment of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano IRCCS; cDepartment of Medicine and Surgery, University of Milan Bicocca; e-mail: [email\u00a0protected]; eCentro Interuniversitario di Fisiologia Clinica e Ipertensione, Universit\u00e0 degli Studi di Milano, Milan, Italy; fax: +39 02 619112901"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AE, adverse events; Abbreviations: ACE, angiotensin-converting enzyme; Accepted 28 June, 2016; BP, blood pressure; CHD, coronary heart disease; CI, confidence interval; NNT, number needed to treat; RCT, randomized controlled trial; RR, risk ratio; Received 13 May, 2016; Revised 16 June, 2016; aDepartment of Cardiology, Helena Venizelou Hospital, Athens, Greece; bDepartment of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano IRCCS; cDepartment of Medicine and Surgery, University of Milan Bicocca; e-mail: [email\u00a0protected]; eCentro Interuniversitario di Fisiologia Clinica e Ipertensione, Universit\u00e0 degli Studi di Milano, Milan, Italy; fax: +39 02 619112901","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I4210134201"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042107498","display_name":"Alberto Zanchetti","orcid":"https://orcid.org/0000-0003-4796-7959","observed_orcids":["https://orcid.org/0000-0003-4796-7959"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210134201","display_name":"IRCCS Istituto Auxologico Italiano","ror":"https://ror.org/033qpss18","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210134201","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Alberto Zanchetti","raw_affiliation_strings":["to Prof Alberto Zanchetti, Direzione Scientifica, Istituto Auxologico Italiano, Via L. Ariosto, 13, I-20145 Milano, Italy. Tel: +39 02 619112237; fax: +39 02 619112901; e-mail: [email\u00a0protected]","AE, adverse events; Abbreviations: ACE, angiotensin-converting enzyme; Accepted 28 June, 2016; BP, blood pressure; CHD, coronary heart disease; CI, confidence interval; NNT, number needed to treat; RCT, randomized controlled trial; RR, risk ratio; Received 13 May, 2016; Revised 16 June, 2016; aDepartment of Cardiology, Helena Venizelou Hospital, Athens, Greece; bDepartment of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano IRCCS; cDepartment of Medicine and Surgery, University of Milan Bicocca; e-mail: [email\u00a0protected]; eCentro Interuniversitario di Fisiologia Clinica e Ipertensione, Universit\u00e0 degli Studi di Milano, Milan, Italy; fax: +39 02 619112901"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"to Prof Alberto Zanchetti, Direzione Scientifica, Istituto Auxologico Italiano, Via L. Ariosto, 13, I-20145 Milano, Italy. Tel: +39 02 619112237; fax: +39 02 619112901; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I4210134201"]},{"raw_affiliation_string":"AE, adverse events; Abbreviations: ACE, angiotensin-converting enzyme; Accepted 28 June, 2016; BP, blood pressure; CHD, coronary heart disease; CI, confidence interval; NNT, number needed to treat; RCT, randomized controlled trial; RR, risk ratio; Received 13 May, 2016; Revised 16 June, 2016; aDepartment of Cardiology, Helena Venizelou Hospital, Athens, Greece; bDepartment of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano IRCCS; cDepartment of Medicine and Surgery, University of Milan Bicocca; e-mail: [email\u00a0protected]; eCentro Interuniversitario di Fisiologia Clinica e Ipertensione, Universit\u00e0 degli Studi di Milano, Milan, Italy; fax: +39 02 619112901","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I4210134201"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5042107498"],"corresponding_institution_ids":["https://openalex.org/I189158943","https://openalex.org/I4210134201"],"apc_list":null,"apc_paid":null,"fwci":1.9763,"has_fulltext":false,"cited_by_count":126,"citation_normalized_percentile":{"value":0.88479263,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"34","issue":"10","first_page":"1921","last_page":"1932"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12075","display_name":"Sodium Intake and Health","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7419999837875366},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.9549999833106995},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8019999861717224},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8849999904632568},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.859000027179718},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.7960000038146973},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.9570000171661377},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.8740000128746033},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.5299999713897705},{"id":"https://openalex.org/keywords/head-to-head-comparison","display_name":"head-to-head comparison","score":0.8519999980926514},{"id":"https://openalex.org/keywords/drug-class-comparison","display_name":"drug class comparison","score":0.4959999918937683},{"id":"https://openalex.org/keywords/treatment-burden","display_name":"treatment burden","score":0.42899999022483826},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.3490000069141388},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.4830000102519989},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9051623940467834},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.8329758048057556},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.8254050016403198},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8246886730194092},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7859055995941162},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5842854976654053},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5303118228912354},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5253847241401672},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3334701657295227},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004232","descriptor_name":"Diuretics","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D028761","descriptor_name":"Withholding Treatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057911","descriptor_name":"Angiotensin Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/hjh.0000000000001052","doi":"https://doi.org/10.1097/hjh.0000000000001052","is_oa":false,"landing_page_url":"https://doi.org/10.1097/hjh.0000000000001052","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},{"id":"pmid:27454050","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27454050","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hypertension","raw_type":"Journal Article"},{"id":"pmh:oai:boa.unimib.it:10281/131636","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10281/131636","pdf_url":null,"source":{"id":"https://openalex.org/S4306401259","display_name":"BOA (University of Milano-Bicocca)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":84,"referenced_works":["https://openalex.org/W157267557","https://openalex.org/W180946569","https://openalex.org/W1492717268","https://openalex.org/W1532542861","https://openalex.org/W1979030376","https://openalex.org/W1983255569","https://openalex.org/W1983526026","https://openalex.org/W1984061204","https://openalex.org/W1985693949","https://openalex.org/W1990845916","https://openalex.org/W1996214493","https://openalex.org/W2001933911","https://openalex.org/W2003670762","https://openalex.org/W2008935865","https://openalex.org/W2011634028","https://openalex.org/W2011713510","https://openalex.org/W2016503459","https://openalex.org/W2028633414","https://openalex.org/W2029384360","https://openalex.org/W2040888535","https://openalex.org/W2044773944","https://openalex.org/W2047025702","https://openalex.org/W2047335781","https://openalex.org/W2049258388","https://openalex.org/W2050003957","https://openalex.org/W2056976690","https://openalex.org/W2059647022","https://openalex.org/W2068519950","https://openalex.org/W2073756362","https://openalex.org/W2082281095","https://openalex.org/W2094295833","https://openalex.org/W2103596506","https://openalex.org/W2103881469","https://openalex.org/W2104423475","https://openalex.org/W2106244081","https://openalex.org/W2107860946","https://openalex.org/W2109689720","https://openalex.org/W2109861453","https://openalex.org/W2110880027","https://openalex.org/W2111421663","https://openalex.org/W2120179549","https://openalex.org/W2120235169","https://openalex.org/W2121708260","https://openalex.org/W2129991662","https://openalex.org/W2133217116","https://openalex.org/W2136115956","https://openalex.org/W2138119952","https://openalex.org/W2138670606","https://openalex.org/W2145555664","https://openalex.org/W2152178651","https://openalex.org/W2152798629","https://openalex.org/W2160258470","https://openalex.org/W2160643831","https://openalex.org/W2167407330","https://openalex.org/W2167557672","https://openalex.org/W2169506520","https://openalex.org/W2170020414","https://openalex.org/W2171735087","https://openalex.org/W2172032309","https://openalex.org/W2228560625","https://openalex.org/W2312400976","https://openalex.org/W2312999996","https://openalex.org/W2323393982","https://openalex.org/W2330187990","https://openalex.org/W2332533900","https://openalex.org/W2399404195","https://openalex.org/W2562329777","https://openalex.org/W2615684303","https://openalex.org/W3021250193","https://openalex.org/W3110805540","https://openalex.org/W3156148333","https://openalex.org/W4230196112","https://openalex.org/W4232706911","https://openalex.org/W4236191630","https://openalex.org/W4238900290","https://openalex.org/W4240221372","https://openalex.org/W4240983006","https://openalex.org/W4241808485","https://openalex.org/W4242344507","https://openalex.org/W4242869084","https://openalex.org/W4243535553","https://openalex.org/W4245326396","https://openalex.org/W4246064375","https://openalex.org/W4249513922"],"related_works":["https://openalex.org/W7162667867","https://openalex.org/W7167829712","https://openalex.org/W2021458034","https://openalex.org/W2460573774","https://openalex.org/W2183041533","https://openalex.org/W2007513331","https://openalex.org/W2782134811","https://openalex.org/W2011713510","https://openalex.org/W2939872307","https://openalex.org/W2005154004"],"abstract_inverted_index":{"BACKGROUND:":[0],"Choice":[1],"of":[2,12,19,34,50,68,82,92,107,112,146,184,222,241,251,263,275,281],"antihypertensive":[3,252,309],"drugs":[4,55,147,283],"is":[5,70,246,284],"also":[6,237,303],"based":[7],"on":[8,139,157],"the":[9,181,213,249,260],"expected":[10],"burden":[11],"adverse":[13,29,59,116,142,152,193,223,244,291],"events":[14,30,60,110,117,153,194,224,245,277],"associated":[15,216],"with":[16,63,95,98,180,206,217,232],"each":[17],"class":[18,91,215],"agents,":[20],"and":[21,65,103,111,129,253],"we":[22],"have":[23],"recently":[24],"identified":[25],"treatment":[26,35,84,113,288,306],"discontinuation":[27,69],"for":[28,58,72,115,141,151,243,259,290],"as":[31],"a":[32,218],"measure":[33],"tolerability":[36],"frequently":[37],"reported":[38],"in":[39,77,87,202,268],"randomized":[40,270],"controlled":[41],"trials":[42],"(RCTs).":[43],"OBJECTIVES:":[44],"To":[45],"investigate":[46],"whether":[47,66],"all":[48,73,279],"classes":[49,74,145,280],"blood":[51],"pressure":[52],"(BP)":[53],"lowering":[54],"increase":[56,192],"discontinuations":[57,114,140,150,242,289,301],"when":[61,75,229,294],"compared":[62,76,94,231],"placebo":[64,96,196],"risk":[67,159,221],"similar":[71],"head-to-head":[78,131,203,230],"RCTs.":[79],"METHODS:":[80],"RCTs":[81,125,132,205],"BP-lowering":[83,282],"were":[85,118,212],"subdivided":[86],"groups":[88,269],"according":[89],"to":[90,248,271,305],"drug":[93],"or":[97],"other":[99,207,233,254],"classes.":[100,234],"Risk":[101],"ratios":[102],"95%":[104],"confidence":[105],"intervals":[106],"major":[108],"cardiovascular":[109,255,276],"calculated":[119],"(random-effects":[120],"model).":[121],"RESULTS:":[122],"Thirty-eight":[123],"placebo-controlled":[124],"(147":[126],"788":[127],"patients)":[128,135],"37":[130],"(242":[133],"481":[134],"provided":[136],"comparative":[137],"information":[138],"events.":[143],"All":[144],"significantly":[148,191,219],"increased":[149,287],"over":[154,195],"those":[155],"occurring":[156],"placebo:":[158],"ratio":[160,198,226],"diuretics":[161],"2.23":[162],"(1.32-3.76),":[163],"beta-blockers":[164],"2.88":[165],"(1.58-5.28),":[166],"calcium":[167],"antagonists":[168],"2.03":[169],"(1.17-3.56),":[170],"angiotensin-converting":[171],"enzyme":[172],"inhibitors":[173],"2.78":[174],"(1.37-5.47),":[175],"central":[176],"agents":[177],"1.74":[178],"(1.24-2.45),":[179],"single":[182],"exception":[183],"angiotensin":[185,209,295],"receptor":[186,210,296],"blockers,":[187],"which":[188,257],"did":[189],"not":[190],"[risk":[197,225],"1.13":[199],"(0.78-1.62)].":[200],"Similarly,":[201],"comparison":[204],"classes,":[208],"blockers":[211,297],"only":[214],"lower":[220],"0.71":[227],"(0.58-0.87)]":[228],"Regression":[235],"analysis":[236],"shows":[238],"that":[239],"incidence":[240,262],"proportional":[247],"number":[250],"drugs,":[256],"accounts":[258],"high":[261],"this":[264],"outcome":[265],"often":[266,307],"found":[267],"placebo.":[272],"CONCLUSION:":[273],"Reduction":[274],"by":[278,286],"accompanied":[285],"events,":[292],"except":[293],"are":[298,302],"used.":[299],"Treatment":[300],"related":[304],"accompanying":[308],"agents.":[310]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2509102166","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":18},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-09-16T00:00:00"}
